Thermo Fisher Scientific
TMO | NYSE
$691.33
-$8.89 (-1.27%)
At close: Nov 16, 2026, 4:00 PM ET
$691.33
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 6:41 PM ET
Thermo Fisher Scientific Company Profile
Company profile explainedCompany Profile
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Marc N. Casper | Chairman & CEO |
| James Meyer | Senior Vice President & Chief Financial Officer |
| Ryan J. Snyder | Senior Vice President & Chief Information Officer |
| Alan J. Malus | Senior Vice President of Strategy & Corporate Development |
| Gianluca Pettiti | President, COO & President of Products and Technologies |
| Joseph R. Holmes | Vice President & Chief Accounting Officer |
| Karen E. Nelson | Chief Scientific Officer |
| Lisa Britt | Chief Human Resources Officer & Senior Vice President |
| Rafael Tejada | Vice President of Investor Relations |
| Sandy Pound | Vice President & Chief Communications Officer |
| Thomas Bailey Shropshire Jr. | Senior Vice President and General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 4 | Filing |
| Oct 30, 2026 | 4 | Filing |
| Oct 30, 2026 | 8-K | Current Report |
| Oct 30, 2026 | 10-Q | Quarterly Report |
| Oct 21, 2026 | 8-K | Current Report |
| Sep 29, 2026 | 4 | Filing |
| Sep 29, 2026 | 4 | Filing |
| Sep 29, 2026 | 4 | Filing |
| Sep 29, 2026 | 4 | Filing |
| Sep 29, 2026 | 4 | Filing |
Thermo Fisher Scientific
| Country | United States |
| IPO Date | Mar 17, 1980 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 125,000 |
| CEO | Marc N. Casper |
Contact Details
168 Third Avenue Waltham,
Massachusetts 02451 United States
Stock Details
| Ticker Symbol | TMO |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000097745 |
| CUSIP Number | 883556102 |
| ISIN Number | US8835561023 |
| SIC Code | 3829 |
Recent News
- 8 days ago / zacks.comShould You Continue to Hold TMO Stock in Your Portfolio?
- 11 days ago / benzinga.comThermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
- 11 days ago / businesswire.comThermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
- 11 days ago / businesswire.comThermo Fisher Scientific Announces Quarterly Dividend
- 22 days ago / gurufocus.comIs TMO Overvalued? DCF Says Worth $352
- 26 days ago / seekingalpha.comThermo Fisher: You Don't Need A Microscope To See The Growth Anymore
- 26 days ago / fool.comThermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
- 27 days ago / gurufocus.comThermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates
- 27 days ago / seekingalpha.comThermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript
- 27 days ago / zacks.comTMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
Add to Watchlist
Select watchlists to add or remove TMO